-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
ArriVent BioPharma, Inc. quarterly Employee-related Liabilities, Current history and growth rate from Q4 2023 to Q2 2024.
- ArriVent BioPharma, Inc. Employee-related Liabilities, Current for the quarter ending June 30, 2024 was $2.04M.